Elisabeth Casademunt

Title: Innovations by Elisabeth Casademunt

Introduction

Elisabeth Casademunt is a notable inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. With a total of 2 patents, her work has the potential to impact medical treatments and therapies.

Latest Patents

Among her latest patents are "Recombinantly produced human factor VIII and IX" and "Processing of recombinant human G-CSF precursor." The first patent involves a recombinant human factor VIII or IX protein that possesses a human glycosylation pattern while being devoid of N-glycolylneuraminic acid and/or the carbohydrate group Galα-3Gal. The second patent focuses on a G-CSF precursor that includes a signal peptide and a G-CSF peptide, where the signal peptide has the sequence of the human wild-type signal peptide of the human G-CSF/b molecule with at least one of the specified mutations.

Career Highlights

Elisabeth is currently employed at Octapharma AG, a company known for its innovative approaches in the field of human proteins. Her work at Octapharma AG has allowed her to further her research and development efforts in biotechnology.

Collaborations

Elisabeth has collaborated with several professionals in her field, including Carola Schröder and Helena Sandberg. These collaborations have contributed to her success and the advancement of her research projects.

Conclusion

Elisabeth Casademunt's contributions to biotechnology through her patents and work at Octapharma AG highlight her role as an influential inventor. Her innovative approaches continue to pave the way for advancements in medical treatments.